References
- The Global Initiative for Chronic Obstructive Lung Disease: GOLD [homepage on the Internet] Available from: http://www.goldcopd.comAccessed May 4, 2016
- BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
- ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
- SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
- AlmagroPCabreraFJDiezJWorking Group on COPD, Spanish Society of Internal MedicineComorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) studyChest201214251126113323303399
- SindenNJStockleyRASystemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidenceThorax2010651093093620627907
- FabbriLMLuppiFBeghéBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120421218166598
- SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
- LawMRHackshawAKA meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effectBMJ199731571128418469353503
- BiskobingDMCOPD and osteoporosisChest2002121260962011834678
- CummingsSRNevittMCBrownerWSRisk factors for hip fracture in white women. Study of Osteoporotic Fractures Research GroupN Engl J Med1995332127677737862179
- DuboisEFRöderEDekhuijzenPNZwindermanAESchweitzerDHDual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimensChest200212151456146312006428
- LuceyDRClericiMShearerGMType 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseasesClin Microbiol Rev1996945325628894351
- Lung Health Study Research GroupEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med2000343261902190911136260
- PauwelsRALöfdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med1999340251948195310379018
- FergusonGTCalverleyPMAndersonJAPrevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health studyChest200913661456146519581353
- HalpernMTSchmierJKVan KerkhoveMDWatkinsMKalbergCJImpact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysisAnn Allergy Asthma Immunol200492201207 Quiz 207–208, 26714989387
- JonesAFayJKBurrMStoneMHoodKRobertsGInhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary diseaseCochrane Database Syst Rev20021CD00353711869676
- KuoHCChangWCYangKDKawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort studyBMC Pediatr2013133823522327
- Mayo Clinic [webpage on the Internet]Risk Factors Available from: http://www.mayoclinic.org/diseases-conditions/osteoporosis/basics/risk-factors/con-20019924Accessed May 4, 2016
- WenCPLevyDTChengTYHsuCCTsaiSPSmoking behaviour in Taiwan, 2001Tob Control200514suppl 1i51i5515923450
- BlackSKushnerISamolsDC-reactive proteinJ Biol Chem200427947484874849015337754
- LiangBFengYThe association of low bone mineral density with systemic inflammation in clinically stable COPDEndocrine201242119019522198912
- SinDDLacyPYorkEManSFEffects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170776076515229100
- OzolDAysanTSolakZAMogulkocNVeralASebikFThe effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patientsRespir Med200599121494150015946834
- CrisafulliEMenéndezRHuertaASystemic inflammatory pattern of patients with community-acquired pneumonia with and without COPDChest201314341009101723187314
- KoFWLeungTFWongGWMeasurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20094798619436689
- HattotuwaKLGizyckiMJAnsariTWJefferyPKBarnesNCThe effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy studyAm J Respir Crit Care Med2002165121592159612070058
- ItoKItoMElliottWMDecreased histone deacetylase activity in chronic obstructive pulmonary diseaseN Engl J Med2005352191967197615888697
- MathioudakisAGAmanetopoulouSGGialmanidisIPImpact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?Respirology201318114715322985270
- SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
- JonesPWWillitsLRBurgePSCalverleyPMInhaled Steroids in Obstructive Lung Disease in Europe study investigatorsDisease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J2003211687312570111
- CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- van der ValkPMonninkhofEvan der PalenJZielhuisGvan HerwaardenCEffect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyAm J Respir Crit Care Med2002166101358136312406823
- KiyokawaHMuroSOgumaTImpact of COPD exacerbations on osteoporosis assessed by chest CT scanCOPD20129323524222360380
- XiaomeiWHangXLinglingLXuejunLBone metabolism status and associated risk factors in elderly patients with chronic obstructive pulmonary disease (COPD)Cell Biochem Biophys201470112913424633456
- BerryMJRejeskiWJAdairNEZaccaroDExercise rehabilitation and chronic obstructive pulmonary disease stageAm J Respir Crit Care Med199916041248125310508815
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
- SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
- Soler-CataluñaJJMartinez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- TattersfieldAEHarrisonTWHubbardRBMortimerKSafety of inhaled corticosteroidsProc Am Thorac Soc20041317117516113431
- ChowSNHuangCCLeeYTDemographic characteristics and medical aspects of menopausal women in TaiwanJ Formos Med Assoc199796108068119343980
- IsaacsAJBrittonARMcPhersonKUtilisation of hormone replacement therapy by women doctorsBMJ19953117017139914018520274